AI-powered investment research.
AI-powered performance.
Bridging the gap, by giving sophisticated ASX investors an institutional edge.
Deep Research
Institutional-quality analysis across 450+ ASX companies
Portfolio Clarity
Know exactly which companies deserve your attention
Answers On Demand Coming Soon
Ask anything about any company, anytime
The Problem
Ever wondered if the research you're reading can be trusted?
Whether it truly has your best interests at heart?
Or whether it was done with the rigour and depth you'd expect?
Who's really behind the research?
Broker research comes with conflicts. They're selling financial products, not giving you honest analysis. Their "buy" call might be their sales team's target.
Whose interests are they serving?
Most research exists to generate trading commissions, not to help you build wealth. The incentives are misaligned and you're the one who pays for it.
How deep does it actually go?
A one-page summary and a price target isn't research. Proper analysis means understanding the business model, the financials, the risks, and what it's actually worth.
Is there even research for it?
Most brokers cover the ASX 50. Maybe the ASX 100. The other 1,900+ listed companies? You're on your own.
We built Alpha Insights to fix this.
How It Works
Three steps. Better decisions.
1
Look up your companies.
Search any ASX company and get a full breakdown -- business model, financials, valuation, risks, and a fair value estimate. Know exactly what you own and what it's worth.
2
See our best ideas.
Browse our model portfolios -- our highest-conviction long and short positions with the reasoning behind every call.
3
Make better decisions.
Use our research to act, or to pressure-test your own thinking. Either way, you walk away more informed and better positioned.
What's Included
Everything you need to invest with confidence.
Featured
Portfolio Strategy Notes
Direct investment updates with real-time positioning calls. Our October 2025 sell signal helped members sidestep a 6% drawdown. Our January 2026 exit call avoided the Iran-driven market downturn. Downside protection that more than pays for itself.
Featured
Model Portfolios
Our highest-conviction long/short and long-only positions, built from our forward-tested research. Your starting point for portfolio construction.
450+ Company Research Reports
Full company analysis through the Research Portal -- business model, financials, valuation, risks, and fair value estimate.
Economic Intelligence
Monthly bottom-up macroeconomic analysis. What's happening in the economy, where the risks are, and what it means for your portfolio.
Comparison & Initiation Alerts
When a company has a material update, we re-analyse and compare to our previous view. See exactly what changed, why the valuation moved, and what's driving it.
Track Record
Don't take our word for it. Look at the numbers.
Long Only -- Our Top Picks vs ASX 200
15 highest-conviction buy calls, Oct 14 2025 - Mar 2 2026
Our Top 15 Picks (+13.25%)
ASX 200 Benchmark (+3.39%)
Cash Rate (+1.09%)
Our top 15 highest-conviction buy ideas, ranked by our portfolio analysis across the ASX 100 universe. Forward-tested from October 2025 to March 2026 against Bloomberg-adjusted closes.
Market-Neutral Long/Short Portfolio vs Cash Rate
ASX 100, 40% conviction threshold, Oct 14 2025 - Mar 2 2026
L/S Portfolio (+14.78%)
Cash Rate (+1.09%)
Our market-neutral long/short portfolio -- equal proportions of long and short positions, removing market risk from the equation. No directional market exposure. Pure stock selection alpha, substantially outperforming the cash rate.
Portfolio Strategy -- Sell Signals vs ASX 200
Timing calls overlaid on the S&P/ASX 200 Total Return, Oct 14 2025 - Mar 11 2026
Alpha Insights Strategy (+3.91%)
S&P/ASX 200 Total Return (-0.25%)
Sell Signal Active
Our Portfolio Strategy sell signals overlaid on the ASX 200 Total Return index. Red zones mark periods where we told members to reduce exposure. The strategy returned +3.91% vs the ASX 200's -0.25% -- a +4.15% alpha from timing alone.
Stocks We Said Buy
| Company | Our Call | Result |
|---|---|---|
| WGX Westgold Resources | Buy | +43.8% |
| BHP BHP Group | Buy | +38.5% |
| WDS Woodside Energy | Buy | +35.3% |
Stocks We Said Avoid
| Company | Our Call | Stock Move |
|---|---|---|
| ZIP Zip Co | Avoid | -62.4% |
| PME Pro Medicus | Avoid | -56.1% |
| XRO Xero | Avoid | -48.2% |
Forward-tested Oct 14, 2025 to Mar 2, 2026 (100 trading days). 87 ASX 100 companies tracked. Prices sourced from Bloomberg (dividend and split adjusted). Past performance is not indicative of future results.
What Members Say
"Your offering is far superior. I find your honesty refreshing."
"A much more sophisticated product than others I've seen."
"The more time I spend, the more I like it. A fantastic product."
"The depth of analysis is outstanding. Alpha Insights genuinely feels like having a buy-side analyst on call."
Read the full review on ProductReview
Is This For You?
Alpha Insights is built for investors who want more.
- You invest in ASX equities and want better research behind your decisions
- You value independent analysis without broker conflicts
- You want portfolio-level thinking, not just stock picks
- You're looking for a fundamental, research-driven approach to investing
- You manage your own portfolio and want to be more informed and productive
Meet Alfie
The analyst in your corner.
Alfie is trained on every report, every model, every macro brief in the Alpha Insights library. Ask it anything -- from quick comparisons to deep-dive valuation questions.
Alfie
Coming Soon
How does CSL's valuation compare to Cochlear?
Both trade at significant premiums to our DCF fair value. CSL is 72% above our estimate with a -30.2% decline since signal. Cochlear is 54% above at -29.8%. CSL has stronger earnings growth but Cochlear has a wider economic moat. On a risk-adjusted basis, both remain overvalued in our framework.
Which ASX100 longs have the best risk/reward right now?
Our highest-conviction positions are Westgold Resources (WGX, 77% undervalued, +43.8% since signal) and Aurizon Holdings (AZJ, 65% undervalued, +29.8%). Both have strong free cash flow visibility and trade well below our base-case DCF. BHP remains a core position at +38.5% but is approaching fair value.
Pricing
Simple pricing. No surprises.
Premium
$500
per year -- 7-day free trial
- 450+ Company Research Reports
- Portfolio Strategy Notes
- Model Portfolios
- Economic Intelligence
- Comparison & Initiation Alerts
- Full Research Portal access
Alfie Add-On
$500
per year -- requires Premium
- AI Analyst trained on full research library
- Ask anything about any ASX company
- Available 24/7
- Deep-dive valuation questions
- Portfolio-specific insights
Not convinced after 7 days? Email [email protected]
FAQ
Frequently asked questions.
Our AI is a tool, not the analyst. It's guided by a former buy-side analyst with 7 years of experience. Every model, every valuation framework, and every output is built on institutional methodology. The AI extends our capacity -- it doesn't replace the thinking. Every output is human-verified, and all financial data is referenced and checked against Bloomberg.
We're independent -- no broker relationships, no commissions, no products to sell. Our research covers 450+ companies with institutional-depth analysis. Most services give you a price target and a paragraph. We give you the full breakdown.
Our Portfolio Strategy Notes alone have called two major market downturns, helping members sidestep significant losses. One good decision pays for years of subscription.
Yes. Even if you hold 5 companies, having deep analysis on each one gives you confidence in what you own and clarity on when to act.
7-day free trial, cancel anytime. No lock-in, no exit fees. Email [email protected] if you have any issues.
Through the Research Portal -- a dedicated platform for Premium members. Search any company, browse portfolios, read macro updates.
Company reports are updated when material events occur. Economic Intelligence is monthly. Portfolio Strategy Notes are issued as needed.
No. The research is written to be clear and actionable. If you invest in ASX stocks and want to be better informed, it's built for you.
Get Started
Insightful research. Investment clarity. Successful outcomes.
7-day free trial. Cancel anytime. No risk.
Questions? [email protected]